CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sarepta Therapeutics, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2026-00166 filed by Sarepta Therapeutics, Inc. et al. on 2025-12-02. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2026-00166

Filing Date

2025-12-02

Accorded Filing Date

2025-12-02

Institution Decision Date

โ€”

Last Modified Date

2026-04-25

Proceeding Type

IPR

Termination Date

2026-03-25

Trial Status

Terminated

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 19013863
Respondent Patent Number 12298313
Legal Expiration Date
2045-01-08 Active (18.1 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Xiaoying JIN et al
Respondent Tech Center TC 1700 - Chemical & Materials Engineering

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1700 - Chemical & Materials Engineering

Decisions Rendered

1 Total

Proceeding Status

Terminated

Administrative Patent Judges (APJ Panel)

Board Decisions & Rulings (1)

Dismissed Before Institution 2026-03-25
Termination Decision: Pre-DI dismissal
35 USC 314, 35 USC 318

Address and Attorney/Agent Information

58 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Sanofi/Genzyme c/o Morrison & Foerster LLP
Customer Number 89300
Address 755 Page Mill Road, Palo Alto, CA, 94304, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
36844 Joseph Kirk Jr +1 908-981-6911
39150 John Conway +1 908-981-6688
39156 B Creagan +1 617-685-5660
39933 Robert Cerpa +1 650-813-5715
40130 Catherine Polizzi +1 650-813-5651
40564 Anne Collins +1 978-341-0036
42198 Edna Vassilovski +1 857-331-2474
43743 Jeffrey Lee +1 617-610-9638

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 1 proceeding
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 3 U.S. Courts: 1
USPTO PTAB Trial 2026-02-26
IPR2026-00270

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2025-12-02
IPR2026-00167

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (11698377)
Status: Institution Denied
USPTO PTAB Trial 2025-12-02
IPR2026-00168

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (12123880)
Status: Institution Denied
U.S. District Court 2024-07-26
1:24-cv-00882

Genzyme Corporation v. Sarepta Therapeutics, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

96
14

Notice: refund approved NOTICE

2026-03-31 FILING PARTY: BOARD
12

Termination Decision: Pre-DI dismissal TERMINATE

2026-03-25 FILING PARTY: BOARD
13

Petitioner's Refund Request OTHER

2026-03-25 FILING PARTY: PETITIONER
1058

Ex. 1058 Exhibit

2026-03-04 FILING PARTY: PETITIONER
1042

Ex. 1042 Exhibit

2026-03-04 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc